B6.129-Rnf2tm1Mvi/Cnbc
Status | Available to order |
EMMA ID | EM:13229 |
International strain name | B6.129-Rnf2tm1Mvi/Cnbc |
Alternative name | Rnf2tm1Mvi |
Strain type | Targeted Mutant Strains : Conditional mutation |
Allele/Transgene symbol | Rnf2tm1Mvi, |
Gene/Transgene symbol | Rnf2 |
Information from provider
Provider | Miguel Vidal |
Provider affiliation | Centro de Investigaciones Biológicas Margarita Salas |
Genetic information | loxP site 5' to first coding exon (exon) and loxP-flanked PGKneo cassette knocked in (antisense) into Rnf2 IVS 3 |
Phenotypic information | Homozygous:None overt in general. Where best studied, i.e. bone marrow, hypo-cellularity without major consequencesHeterozygous:None obvious |
Breeding history | Backcrossed 4-5 times into C57BL/6 |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | not known |
Information from EMMA
Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
Animals used for archiving | heterozygous C57BL/6J |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Non-specific syndromic intellectual disability / Orphanet_528084
Literature references
- Inactivation of the polycomb group protein Ring1B unveils an antiproliferative role in hematopoietic cell expansion and cooperation with tumorigenesis associated with Ink4a deletion.;Calés Carmela, Román-Trufero Mónica, Pavón Leticia, Serrano Iván, Melgar Teresa, Endoh Mitsuhiro, Pérez Claudia, Koseki Haruhiko, Vidal Miguel, ;2008;Molecular and cellular biology;28;1018-28; 18039844
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).